Inhibition of angiogenesis by humulone, a bitter acid from beer hop

被引:82
作者
Shimamura, M
Hazato, T
Ashino, H
Yamamoto, Y
Iwasaki, E
Tobe, H
Yamamoto, K
Yamamoto, S
机构
[1] Tokyo Metropolitan Inst Med Sci, Med Res Ctr, Rinshoken, Bunkyo Ku, Tokyo 1138613, Japan
[2] Tokyo Metropolitan Inst Med Sci, Dept Mol Biol, Bunkyo Ku, Tokyo 1138613, Japan
[3] Kochi Natl Coll Technol, Nankoku, Kochi 7838508, Japan
[4] Univ Tokushima, Sch Med, Dept Biochem, Tokushima 7708503, Japan
[5] Kyoto Womens Univ, Fac Home Econ, Higashiyama Ku, Kyoto 6058501, Japan
关键词
angiogenesis; humulone; bitter acid; beer hop; cyclooxygenase; COX-2; VEGF; endothelial cells; tube formation; cancer;
D O I
10.1006/bbrc.2001.5934
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
On the basis of our previous finding that humulone, a bitter acid from beer hop extract, was a potent inhibitor of bone resorption and inhibited the catalytic activity of cyclooxygenase-2 (COX-2) and more potently the transcription of the COX-2 gene, we examined the effect of humulone on angiogenesis, using chick embryo chorioallantoic membranes (CAMs) and vascular endothelial and tumor cells. Humulone significantly prevented in vivo angiogenesis in CAM in a dose-dependent manner with an ED50 of 1.5 mug/CAM. Humulone also inhibited in vitro tube formation of vascular endothelial cells. Moreover, it suppressed the proliferation of endothelial cells and the production of vascular endothelial growth factor (VEGF), an angiogenic growth factor, in endothelial and tumor cells. Thus, humulone is a potent angiogenic inhibitor, and may be a novel powerful tool for the therapy of various angiogenic diseases involving solid tumor growth and metastasis. (C) 2001 Academic Press.
引用
收藏
页码:220 / 224
页数:5
相关论文
共 25 条
[1]   Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance [J].
Boehm, T ;
Folkman, J ;
Browder, T ;
OReilly, MS .
NATURE, 1997, 390 (6658) :404-407
[2]   ANGIOGENESIS IN CANCER, VASCULAR, RHEUMATOID AND OTHER DISEASE [J].
FOLKMAN, J .
NATURE MEDICINE, 1995, 1 (01) :27-31
[3]   NS-398, A NEW ANTIINFLAMMATORY AGENT, SELECTIVELY INHIBITS PROSTAGLANDIN-G/H SYNTHASE CYCLOOXYGENASE (COX-2) ACTIVITY IN-VITRO [J].
FUTAKI, N ;
TAKAHASHI, S ;
YOKOYAMA, M ;
ARAI, I ;
HIGUCHI, S ;
OTOMO, S .
PROSTAGLANDINS, 1994, 47 (01) :55-59
[4]   Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A:: Roles of the nuclear factor of activated T cells and cyclooxygenase 2 [J].
Hernández, GL ;
Volpert, OV ;
Iñiguez, MA ;
Lorenzo, E ;
Martínez-Martínez, S ;
Grau, R ;
Fresno, M ;
Redondo, JM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (05) :607-620
[5]   Prostaglandin synthase 2 [J].
Herschman, HR .
BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1996, 1299 (01) :125-140
[6]  
Jones MK, 1999, NAT MED, V5, P1418
[7]   INHIBITION OF VASCULAR ENDOTHELIAL GROWTH FACTOR-INDUCED ANGIOGENESIS SUPPRESSES TUMOR-GROWTH INVIVO [J].
KIM, KJ ;
LI, B ;
WINER, J ;
ARMANINI, M ;
GILLETT, N ;
PHILLIPS, HS ;
FERRARA, N .
NATURE, 1993, 362 (6423) :841-844
[8]   Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo [J].
Liu, XH ;
Kirschenbaum, A ;
Yao, S ;
Lee, R ;
Holland, JF ;
Levine, AC .
JOURNAL OF UROLOGY, 2000, 164 (03) :820-825
[9]  
Masferrer JL, 2000, CANCER RES, V60, P1306
[10]   INHIBITION OF LYMPHOCYTE-INDUCED ANGIOGENESIS BY FREE-RADICAL SCAVENGERS [J].
MONTE, M ;
DAVEL, LE ;
DELUSTIG, ES .
FREE RADICAL BIOLOGY AND MEDICINE, 1994, 17 (03) :259-266